Aqueous Agenda: Navigating Nasal

Aqueous Agenda: Navigating Nasal Vaccines

Thursday • May 4, 2023 • 9:00–10:00 AM CET • Auditorium Level 3
Moderator: Regina Scherließ, Dr. rer. nat.

Intranasal Vaccination: Rationale, Progress and Challenges
Julie Suman
Aptar Pharma
Dual Nasal and Pulmonary Targeting to Optimize Mucosal Absorption: Exploring Methods, Devices and Formulations
Orest Lastow
Iconovo

Discover More

Synergies of Inhalation Product Development and Spray Characterization
Mark Ignaczak, David Wilcox and Maria Smith
Catalent and Proveris Scientific Corporation
In Vitro Epithelial Models to Aid Nasal and Pulmonary Product Development
Jon Volmer and Lynn Allen
MedPharm
An Overview of Lipid Nanoparticle-based mRNA Formulations for Inhaled Delivery
Bernhard Muellinger and Nicolas Buchmann
Recipharm
Development of a Novel Device Targeting Drug Delivery into the Olfactory Region of the Nasal Cavity
Goncalo Farias
Aptar Pharma
Chemical Imaging by Raman Spectrometer for Particle Characterization of an Aqueous Nasal Spray
Mridul Majumder
M2M Pharmaceuticals
Microfluidic Aerosol Generation: Breaking Free from Capillary Wave Theory
Jason Brenker
Monash University
Using a Physiologically Based Pharmacokinetic Model to Investigate the Relationship Between Device, Orientation, Deposition Pattern and the Systemic Exposure of Sumatriptan Nasal Solutions
Will Ganley
Nanopharm
Formulation Technologies Assessment for the Development of Intranasal Powders Comprising a Peptide
Irene Rossi and Paul Shields
Nanopharm
EM
Tuneable Nebulizer Platform for Targeted Inhalation Drug Delivery
Elspeth Macdonald
Nebu-Flow
Usability Evaluation of a Novel, User-Independent Unit Dose Nasal Spray via Human Factors Studies
Sabrina Falloon and Adam Gibbons
Recipharm
Benchmarking of Particle Engineering Strategies for Nasal Powder Delivery: Characterization of Nasal Deposition Using the Alberta Idealized Nasal Inlet
Patricia Henriques
University of Coimbra
In Vitro Methodologies for the Screening of Nasal Powders: Polymer-Based Formulations
Patricia Henriques
University of Coimbra
Investigations into the Relationship Between Spray Dried Powder Particle Size and Deposition in Nose and Lung Analogues when Actuated from a Nasal Device
Jordan Potts
Upperton Pharma Solutions
Multi-Factor Understanding of Vibrating-Mesh Nebulization: Placing Patient Needs at the Center of the Combination Product Development Process
Daniel Lock
Vectura
CO-ORGANIZERS
CONFERENCE SUPPORTERS
WORKSHOP PRESENTERS
EXHIBITORS
↑ Back to Top